When was PiroGon founded?

PiroGon was founded in 2021 and raised its 1st funding round 1 year after it was founded.

Where is PiroGon located?

PiroGon is headquartered in New Haven, United States. It is registered at Municipiul BeiuÅ, STR. SPITALULUI, Nr. 8, JudeÈ Bihor, Cod poÈtal 3600.

Who is the current CEO of PiroGon?

Rigu Gupta of PiroGon. They have also founded 1 company.

How many employees does PiroGon have?

As of May 31, 2026, the latest employee count at PiroGon is 5.

Is PiroGon a funded company?

PiroGon is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Jan 20, 2022.

When was the latest funding round of PiroGon?

PiroGon's latest funding was a $***** Seed round on Jan 20, 2022, with participation from 0 investor. Its primary sector is Gastroenterology. In United States, the Gastroenterology sector has seen $541M in funding in 2026 to date.

Where does PiroGon rank among its competitors?

PiroGon ranks 28th amongst 43 active competitors, of which 16 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Ostoform, which secured an undisclosed amount in Oct, 2022.

Who are the top competitors of PiroGon?

PiroGon's top competitors include Vibrant, EndoGastric Solutions and Endo Tools Therapeutics. Among them, Ostoform secured the most recent funding round in October, 2022.

PiroGon - 2026 Company Profile, Team, Funding & Competitors

PiroGon is a seed company based in New Haven (United States), founded in 2021 by Rigu Gupta. It operates as a Developer of medical device for the treatment of acid reflux. PiroGon has raised $1.34M in funding. The company has 43 active competitors, including 16 funded and 5 that have exited. Its top competitors include companies like Vibrant, EndoGastric Solutions and Endo Tools Therapeutics.

Company Details

Developer of medical device for the treatment of acid reflux. The company offers PiroGon Device stimulates and tightens the lower valve by neuromodulation, and stops backward flow of stomach contents.

Website: pirogon.com
Email ID: *****@pirogon.com
Registered Address: Municipiul BeiuÅ, STR. SPITALULUI, Nr. 8, JudeÈ Bihor, Cod poÈtal 3600

Key Metrics

Founded Year

2021

Location

New Haven, United States

Stage

Seed

Total Funding

$1.34M in 1 round

Latest Funding Round

Seed, Jan 20, 2022, $*****

Ranked

28^th among 43 active competitors

Employee Count

5 as on May 31, 2026

Similar Companies

Vibrant & 54 more

View PiroGon's full profile

PiroGon is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
CALITI BUSINES IMPEX SRL CIN: 6463160 , Romania, Active		-	-	-

PiroGon has raised a total funding of $1.34M over 1 round.

Here is the list of recent funding rounds of PiroGon:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Jan 20, 2022	3307657	Seed	5035619	3403184	7143463	8928135

Access funding benchmarks and valuations. Sign up today!

View details of PiroGon's funding rounds and investors

The founders of PiroGon is Rigu Gupta. Rigu Gupta is the CEO of PiroGon.

Here are the details of PiroGon's key team members:

Rigu Gupta: Founder & CEO of PiroGon.
Contact Info: 1 email address

View details of PiroGon's Founder profiles and Board Members

PiroGon's employee count trend

PiroGon has 5 employees as of May 26. Here is PiroGon's employee count trend over the years:

Uncover PiroGon's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of PiroGon include Vibrant, EndoGastric Solutions and Endo Tools Therapeutics. Here is the list of Top 10 competitors of PiroGon, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Vibrant 2007, Yokneam Illit (Israel), Series E	Developer of chemical-free vibrating capsules for the treatment of constipation	$25M	Unorthodox Ventures, Sequoia Capital & 3 others	59/100
2nd	EndoGastric Solutions 2002, San Mateo (United States), Series J	Endoluminal solutions for digestive diseases, restoring anatomy and improving patient outcomes	$355M	Advanced Technology Ventures, Canaan & 14 others	56/100
3rd	Endo Tools Therapeutics 2008, Charleroi (Belgium), Series D	Developer of an endoscopic catheter for gastroenterologists	$18.7M	SFPI, Epimede & 3 others	54/100
4th	Rockfield 2014, Galway (Ireland), Funding Raised	Developer of a medical device for the feeding sector	-	EIC Fund, Europa	48/100
5th	EndoChoice 2008, Alpharetta (United States), Acqui-Hired	Range of devices, systems and services for GI specialists	$116M	Council Capital, Envest Private Equity & 12 others	48/100
6th	Enterra Medical 2022, St. Louis Park (United States), Unfunded	Developer of medical device to control chronic symptoms of gastroparesis	-	-	44/100
7th	Implantica 2003, Zug (Switzerland), Funding Raised	Developer of wireless smart body implants for monitoring diseases	-	Ministry of Electronics & Information Technology	43/100
8th	SafeStitch 2005, Miami (United States), Public	Portfolio of products for Gastrointestinal, and Bariatric surgery	$7.58M	-	43/100
9th	Ostoform 2016, Dublin (Ireland), Series B	Developer of mouldable seals for damaged peristomal skin	$4.77M	Halo Business Angel Network, BGF & 5 others	40/100
10th	Integrated Endoscopy 1996, Santa Margarita (United States), Late Stage	Innovating single-use wireless endoscopy for enhanced surgical solutions and patient safety	$20.1M	BrilliMedical, Arcis Capital Partners	39/100
28th	PiroGon 2021, New Haven (United States), Seed	Developer of medical device for the treatment of acid reflux	$1.34M	-	29/100